Luxist Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Eli Lilly plans new 2 billion euro German plant -source - AOL

    www.aol.com/news/lilly-plans-single-digit...

    By Rene Wagner, Klaus Lauer and Andreas Rinke. BERLIN (Reuters) - U.S. pharmaceuticals company Eli Lilly plans to build a new plant in western Germany, sources close to the matter told Reuters ...

  3. InnoCentive - Wikipedia

    en.wikipedia.org/wiki/InnoCentive

    InnoCentive is an open innovation and crowdsourcing company with its worldwide headquarters in Waltham, MA and their EMEA headquarters in London, UK. They enable organizations to put their unsolved problems and unmet needs, which are framed as ‘Challenges’, out to the crowd to address. [1] In the case of InnoCentive, the crowd can either be ...

  4. Josiah K. Lilly Jr. - Wikipedia

    en.wikipedia.org/wiki/Josiah_K._Lilly_Jr.

    Josiah K. Lilly Jr. Lilly in 1913. Josiah Kirby "Joe" Lilly Jr. (September 25, 1893 – May 5, 1966) was a businessman and industrialist who served as president (1948 –53) and chairman of the board (1953–66) of Eli Lilly and Company, the pharmaceutical firm his grandfather, Colonel Eli Lilly, founded in Indianapolis in 1876.

  5. Eli Lilly obesity drug now available in US pharmacies - AOL

    www.aol.com/news/eli-lillys-obesity-drug-now...

    Lilly said Zepbound has been added to the U.S. list of preferred medicines for reimbursement by at least one major pharmacy benefit manager (PBM), Cigna's Express Scripts, and will be added to ...

  6. Eli Lilly's experimental Alzheimer's drug slows progression ...

    www.aol.com/news/eli-lilly-experimental...

    An Alzheimer's drug from Eli Lilly slowed decline of the disease by up to 48%, or about 7 and a half months. The drug comes with risks of serious side effects including brain bleeds.

  7. Eli Lilly, Novo Nordisk stocks soar after weight-loss drug ...

    www.aol.com/finance/eli-lilly-novo-nordisk-soar...

    Lilly will also be testing Mounjaro for additional benefits in a trial that is set to end October 2027. The boost puts Eli Lilly in the top spot for market capitalization among healthcare giants, ...